tiprankstipranks
PharmaDrug Completes Strategic Debenture Issuance
Company Announcements

PharmaDrug Completes Strategic Debenture Issuance

Story Highlights

Pharmadrug (TSE:PHRX) has released an update.

Don't Miss our Black Friday Offers:

PharmaDrug Inc. has successfully issued over $412,000 in debentures to replace its outstanding secured convertible debentures, along with over 8 million common share purchase warrants. These debentures, convertible into common shares at $0.05 each, are secured by a general security agreement and carry no interest unless unpaid at maturity, marking a strategic financial move for the company.

For further insights into TSE:PHRX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskPharmaDrug Debenture Units Issuance Announcement
TipRanks Canadian Auto-Generated NewsdeskPharmaDrug Advances PD-001 for Clinical Trials
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App